Grants and Contributions:
Title:
Development of novel, sensitive, measures of hand-function to expedite clinical
trials for neuromuscular disorders impacting aging in place.
Agreement Number:
1001787
Agreement Value:
$199,980.00
Agreement Date:
Mar 1, 2023 - Jan 14, 2026
Description:
Normal aging and chronic disease can reduce our fine motor skills. However, sensitive outcome measures for assessing hand function and fine motor skills required for activities of daily living are lacking. This is impacting treatment development for late onset neuromuscular conditions affecting hand function in the elderly, such as Myotonic Dystrophy type-1 (DM1), because the lack of PAGE 4 sensitive outcome measures to monitor treatment efficacy is preventing industry investment in clinical trials for these conditions. This project will develop and test novel, sensitive, outcome measures to assess hand function in patients with neuromuscular conditions using the NRC’s bTrained software platform combined with wearable hardware. At the end of the project, a novel outcome measure (consisting of a suite of sensitive hand function assessment exercises on the bTrained platform) will be delivered and be ready for testing in the context of clinical trials. This study directly falls under the objectives of the AiP program by developing tools to facilitate drug discovery for neuromuscular diseases affecting the elderly, and thereby help elderly individuals to remain well and living independently in their homes.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Montreal, Quebec, CA H3A 0G4
Reference Number:
172-2022-2023-Q4-1001787
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
119128981
Recipient Type:
Academia
Additional Information:
This agreement has been amended 1 time(s). The total amended value is $199,980.
Amendment Date
Jan 14, 2026
Recipient's Legal Name:
The Royal Institution for the Advancement of Learning/McGill University
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
NAICS Code:
541710 - R&D in the physical, engineering and life sciences
Amendments: